Abstract
Polyethyleneimine (PEI) is one of the most effective gene delivery systems available today. However, very little is known about its ability to stimulate a systemic immune response and the molecular mechanisms thereof. However, this information is vital for the future development of new gene delivery systems.
Here we address this issue by studying gene expression profiles from spleen lymphocytes after in vivo immunization of mice with PEI formulated with a reporter plasmid (PEI+) or the formulation alone (PEI−). PEI− was found to provoke the activation of genes with important immunostimulatory functions, but without the necessary costimulatory signals. PEI+ resulted in: a mixed Th1/Th2 response; activation of both CD8+ and CD4+ T cells, with a larger effect on CD4+; and FasL-mediated antigen-induced cell death. A comparison of the immune responses of PEI+ with that of the clinically used tetanus toxoid–aluminum phosphate vaccine showed that the DNA vaccine provoked a stronger immune response as compared to the protein vaccine. However, many genes involved in other cellular responses such as apoptosis, stress responses and oncogenesis were activated in PEI+, supporting the theory of immunostimulation by danger genes, but also pointing toward possible adverse reactions such as Alzheimer's disease.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Brown MD, Schätzlein AG, Uchegbu IF . Gene delivery with synthetic (non viral) carriers. Int J Pharm 2001; 229: 1–21.
Ulmer JB et al. Induction of immunity by DNA vaccination: application to influenza and tuberculosis. Behring Inst Mitt 1997; 98: 79–86.
Raz E et al. Intradermal gene immunization: the possible role of DNA uptake in the induction of cellular immunity to viruses. Proc Natl Acad Sci USA 1994; 91: 9519–9523.
Klavinskis LS, Barnfield C, Gao L, Parker S . Intranasal immunization with plasmid DNA–lipid complexes elicits mucosal immunity in the female genital and rectal tracts. J Immunol 1999;162: 254–262.
Gregoriadis G, Saffie R, De Souza JB . Liposome-mediated DNA vaccination. FEBS Lett 1997; 402: 107–110.
Singh M, Briones M, Ott G, O'Hagan D . Cationic microparticles a potent delivery system for DNA vaccines. Proc Natl Acad Sci USA 2000; 97: 811–816.
Roy K, Mao HQ, Huang SK, Leong KW . Oral gene delivery with chitosan–DNA nanoparticles generates immunologic protection in a murine model of peanut allergy. Nat Med 1999; 5: 387–391.
Boussif O et al. A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethyleneimine. Proc Natl Acad Sci USA 1995; 92: 7297–7301.
Godbey WT, Wu KK, Mikos AG . Tracking the intracellular path of poly (ethyleneimine)/DNA complexes for gene therapy. Proc Natl Acad Sci USA 1999; 96: 5177–5181.
Pollard H et al. Polyethylenimine but not cationic lipids promotes transgene delivery to the nucleus in mammalian cells. J Biol Chem 1998; 273: 7505–7511.
Kichler A, Leborgne C, Coeytaux E, Danos O . Polyethyleneimine-mediated gene delivery: a mechanistic study. J Gene Med 2001; 3: 135–144.
Densmore CL et al. Aerosol delivery of robust polyethyleneimine–DNA complexes for gene therapy and genetic immunization. Mol Ther 2000; 1: 180–188.
Plank C, Mechtler K, Szoka Jr FC, Wagner E . Activation of the Complement System by Synthetic DNA Complexes: A Potential barrier of Intravenous Gene Delivery. Hum Gene Ther 7: 1437–1446.
Regnström K et al. Tetanus antigen modulates the gene expression profile of aluminum phosphate in spleen lymphocytes in vivo. Pharmacogenomics J 2002; 2: 57–64.
Teague TK et al. Activation changes the spectrum but not the diversity of genes expressed by T cells. Proc Natl Acad Sci USA 1999; 96: 12691–12696.
Regnström K, Ragnarsson EGE, Artursson P . Expression profiles of clinical relevant diphtheria and tetanus vaccines. Vaccine 2003 (in press).
Ferrari S et al. Polyethyleneimine shows properties of interest for cystic fibrosis gene therapy. Biochim Biophys Acta 1999; 1447: 219–225.
Tamayo P et al. Interpreting patterns of gene expression with self-organizing maps: methods and application to hematopoietic differentiation. Proc Natl Acad Sci USA 1999; 96: 2907–2912.
Liu K et al. IL-15 mimics T cell receptor crosslinking in the induction of cellular proliferation, gene expression, and cytotoxicity in CD8+ memory T cells. Proc Natl Acad Sci USA 2002; 99: 6192–6197.
Jensen TK, Laegreid A, Komorowski J, Hovig E . A literature network of human genes for high-throughput analysis of gene expression. Nat Genet 2001; 28: 21–28.
Rebhan M, Chalifa-Caspi V, Prilusky J, Lancet D . GeneCards: encyclopaedia for genes, proteins and diseases. Trends Genet 1997; 13: 163.
Bustin SA, Jenkins PJ . The growth hormone-insulin-like growth factor-I axis and colorectal cancer. Trends Mol Med 2001; 7: 447–454.
Matzinger P . An innate sense of danger. Semin Immunol 1998; 10: 399–415.
Conley ME, Delacroix DL . Intravascular and mucosal immunoglobulin A: two separate but related systems of immune defense. Ann Intern Med 1987; 106: 892–899.
Mäkelä PH . Vaccines, coming of age after 200 years. FEMS Microbiol Rev 2000; 24: 9–20.
Krishnan S, Haensler J, Meulien P . Paving the way towards DNA vaccines. Nat Med 1995; 1: 521–522.
Roman M et al. Immunostimulatory DNA sequences function as T helper-1-promoting adjuvant. Nat Med 1997; 3: 849–854.
Quiding-Järbrink M et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. J Clin Invest 1997; 99: 1281–1286.
Surh CD, Sprent J . T-cell apoptosis detected in situ during positive and negative selection in the thymus. Nature 1994; 372: 100–103.
Hildeman DA et al. Molecular mechanisms of activated T-cell death in vivo. Curr Opin Immunol 2002; 14: 354–359.
Kiefer MC et al. Modulation of apoptosis by the widely distributed Bcl-2 homologue Bak. Nature 1995; 374: 736–739.
Boise LH et al. Bcl-x, a bcl-2-related gene that functions as a dominant regulator of apoptotic cell death. Cell 1993; 74: 597–608.
Wang K et al. Bcl-2 heterodimerizes in vivo with a conserved homolog, Bax, that accelerates programmed cell death. Cell 1993; 74: 609–619.
Crispe IN . Death and destruction of activated T lymphocytes. Immunol Res 1999; 19: 143–157.
Alderson MR et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J Exp Med 1995; 181: 71–77.
Vito P, Lacana E, D'Adamio L . Interfering with apoptosis: Ca(2+) binding protein ALG-2 and Alzheimer's disease gene ALG-3. Science 1996; 271: 521–525.
Mitchell TC et al. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol 2001; 13: 114–119.
Hamad AR, Schneck JP . Antigen-induced T-cell death is regulated by CD4 expression. Int Rev Immunol 2001; 20: 535–546.
Rebello A et al. Bcl-3 expression promotes cell survival following interleukin 4 deprivation and is controlled by AP1 and AP1 like transcription factors. Mol Cell Biol 2000; 20: 3407–3416.
Tavazoie S, Church GM . Quantitative whole-genome analysis of DNA–protein interactions by in vivo methylase protection in E. coli. Nat Biotechnol 1998; 16: 566–571.
Helander IM, Latva-Kala K, Lounatmaa K . Permeabilizing action of polyethyleneimin on Salmonella typhimurium involves disruption of the outer membrane with lipopolysaccharide. Microbiology 1998; 144: 385–390.
Helander IM, Alakomi HL, Latva-Kala K, Koski P . Polyethyleneimine is an effective permeabilizer of Gram-negative bacteria. Microbiology 1997; 143: 3193–3199.
Lashuel HA et al. Neurodegenerative disease: amyloid pores from pathogenic mutations. Nature 2002; 418: 291.
Godbey WT, Wu KK, Hirasaki GJ, Mikos AG . Improved packing of poly(ethylene-imine)/DNA complexes increases transfection efficiency. Gene Therapy 1999; 6: 1380–1388.
Eisen MB, Spellman PT, Brown PO, Botstein D . Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 1998; 95: 14863–14868.
Acknowledgements
We thank Dr. Diane Burgess, Department of Pharmacy, University of Connecticut for helpful comments. This work was supported by the Swedish Board for Technical Development Grant p11381-1, the Swedish National Network for Drug Development Grant B 6 3368/98 and the Swedish Research Council Grant 621-2001-3563.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Regnström, K., Ragnarsson, E., Köping-Höggård, M. et al. PEI – a potent, but not harmless, mucosal immuno-stimulator of mixed T-helper cell response and FasL-mediated cell death in mice. Gene Ther 10, 1575–1583 (2003). https://doi.org/10.1038/sj.gt.3302054
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.gt.3302054
Keywords
This article is cited by
-
Reversible stabilization of DNA/PEI complexes by reducible click-linkage between DNA and polymer. A new polyplex concept for lowering polymer quantity
Gene Therapy (2023)
-
Enhancement of Nasal HIV Vaccination with Adenoviral Vector-Based Nanocomplexes Using Mucoadhesive and DC-Targeting Adjuvants
Pharmaceutical Research (2014)
-
Efficient Biodistribution and Gene Silencing in the Lung epithelium via Intravenous Liposomal Delivery of siRNA
Molecular Therapy - Nucleic Acids (2013)
-
Intranasal DNA Vaccination Induces Potent Mucosal and Systemic Immune Responses and Cross-protective Immunity Against Influenza Viruses
Molecular Therapy (2011)
-
Intranasal immunization with plasmid DNA encoding spike protein of SARS-coronavirus/polyethylenimine nanoparticles elicits antigen-specific humoral and cellular immune responses
BMC Immunology (2010)